Ryan Stidham is an Assistant Professor of Medicine and a translational scientist, caring exclusively for patients with Crohn’s disease and ulcerative colitis at the University of Michigan Inflammatory Bowel Disease Program in Ann Arbor, Michigan.
Dr. Stidham received his medical degree from the University of Virginia School of Medicine and completed training in Internal Medicine at the University of Pennsylvania. He was a NIH T-32 Research Fellow of Gastroenterology at the University of Michigan. Dr. Stidham holds a Master’s degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health.
What drew you to MiCHAMP?
What drew me to MiCHAMP – When you seat a dozen masters who holistically represent the core domains of health care research and discovery you get more than interesting commentary, you see academic art! Every MiCHAMP member has a voice and contribution. MiCHAMP stimulates unexpected collaborations and provides an incubator for bringing disciplines from across campus together.
What specific expertise do you bring to MiCHAMP?
My methodologic focus is extraction information from unstructured clinical data, specifically imaging and text records. My group quantifies features found in cross-sectional imaging and video data to improve disease phenotyping, specifically in Crohn’s disease and ulcerative colitis.
What are your research interests and how do they tie into MiCHAMP?
My research interest is finding new methods for describing and quantifying disease severity in the inflammatory bowel diseases. Work with MiCHAMP members we have embarked on projects for automating detection of therapeutic response by computational analysis of colonoscopy videos. In addition, we are performing natural language processing of clinical documents to quickly label patient phenotypes merging records from treating physicians, radiologists, and pathologists.
Stidham RW, Liu W, Bishu S, Rice MD, Higgins PDR, Zhu J, Nallamothu BK, Waljee AK. Assessment of Automated Deep Learning Grading of Endoscopic Disease Severity Among Patient with Ulcerative Colitis. JAMA Network Open. 2019. 2019 May.(PubMed)
Wu J, Lubman DM, Kugathasan S, Denson L, Hyams J, Dubinsky M, Griffiths M, Baldassano R, Noe J, Crandall W, Higgins PDR, Stidham RW. Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn’s Disease. Amer Journal of Gastro. 2019 May.(PubMed)
Perl D, Waljee AK, Bishu S, Higgins, PDR, Wasnik AP, Stidham RW. Imaging Features Associated with Failure of Non-Operative Management of Intra-Abdominal Abscesses in Crohn’s Disease. Inflamm Bowel Dis. 2019 April.(Journal Site)
Wright AP, Piper MS, Bishu S, Stidham RW. Flexible sigmoidoscopy identifies most cases of checkpoint inhibitor-induced colitis. Aliment Pharmacol Ther. 2019 April.(PubMed)